IL13 and metabolic dysfunction-associated steatohepatitis: In this line, Hart et al. found higher production of IL-4, IL-5 and IL-13 from intrahepatic lymphocytes of NASH patients, compared to healthy subjects, suggesting a potentially relevant role of type 2 cytokines in NASH progression [122].